RNF20 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.5372999984109E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.557900E-03 |
Normal-vs-Stage2 |
1.022280E-04 |
Normal-vs-Stage3 |
1.59009472255889E-11 |
Normal-vs-Stage4 |
5.32740518366381E-12 |
Stage1-vs-Stage2 |
3.317800E-02 |
Stage1-vs-Stage3 |
1.17200000038231E-07 |
Stage1-vs-Stage4 |
4.9452000050465E-08 |
Stage2-vs-Stage3 |
1.048960E-01 |
Stage2-vs-Stage4 |
3.028100E-02 |
Stage3-vs-Stage4 |
4.887200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.77210000404682E-08 |
Normal-vs-AfricanAmerican |
2.9452000005481E-07 |
Normal-vs-Asian |
4.045000E-01 |
Caucasian-vs-AfricanAmerican |
1.202630E-01 |
Caucasian-vs-Asian |
3.581000E-01 |
AfricanAmerican-vs-Asian |
1.432400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.53159995797125E-09 |
Normal-vs-Female |
7.84919999999856E-05 |
Male-vs-Female |
2.519800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.263800E-03 |
Normal-vs-Age(41-60Yrs) |
1.55815999999254E-05 |
Normal-vs-Age(61-80Yrs) |
6.53059994970562E-09 |
Normal-vs-Age(81-100Yrs) |
1.203090E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.753000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.105600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.278000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.142390E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.181650E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.954600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.682000E-01 |
Normal-vs-Grade 2 |
2.559200E-03 |
Normal-vs-Grade 3 |
7.39159955465141E-10 |
Normal-vs-Grade 4 |
1.63613567139009E-12 |
Grade 1-vs-Grade 2 |
5.461900E-02 |
Grade 1-vs-Grade 3 |
9.400900E-04 |
Grade 1-vs-Grade 4 |
5.78340000001454E-07 |
Grade 2-vs-Grade 3 |
3.5218000000059E-05 |
Grade 2-vs-Grade 4 |
1.07439945828958E-10 |
Grade 3-vs-Grade 4 |
9.640300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.488200E-01 |
Normal-vs-ccB subtype |
1.7785772854495E-12 |
ccA subtype-vs-ccB subtype |
1.11022302462516E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.72090000027936E-07 |
Normal-vs-N1 |
2.09559999999609E-05 |
N0-vs-N1 |
1.070380E-01 |
|
|